GlobeNewswire: Novadip Biosciences Contains the last 10 of 17 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T11:13:18ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2021/10/28/2322559/0/en/Novadip-Biosciences-announces-EUR-19-million-Series-B-financing-backed-by-international-investors.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences announces EUR 19 million Series B financing backed by international investors2021-10-28T11:00:00Z<![CDATA[Novadip Biosciences announces EUR 19 million Series B financing backed by international investors]]>https://www.globenewswire.com/news-release/2021/10/28/2322313/0/en/Novadip-Biosciences-announces-EUR-19-million-Series-B-financing-backed-by-international-investors.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences announces EUR 19 million Series B financing backed by international investors2021-10-28T05:00:00Z<![CDATA[Novadip Biosciences announces EUR 19 million Series B financing backed by international investors]]>https://www.globenewswire.com/news-release/2021/06/15/2246933/0/en/Novadip-Biosciences-reports-positive-data-from-phase-I-study-of-NVD-001-for-spinal-fusion.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences reports positive data from phase I study of NVD-001 for spinal fusion2021-06-15T05:00:00Z<![CDATA[]]>Integration of NVD-001 in intervertebral body cage fusionIntegration of NVD-001 in intervertebral body cage fusionNVD-001 ProductNVD-001 Producthttps://www.globenewswire.com/news-release/2021/03/04/2186959/0/en/Novadip-Biosciences-receives-IND-approval-from-the-FDA-for-regenerative-bone-product-NVD-003.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-0032021-03-04T12:00:00Z<![CDATA[Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003]]>https://www.globenewswire.com/news-release/2021/03/04/2186762/0/en/Novadip-Biosciences-receives-IND-approval-from-the-FDA-for-regenerative-bone-product-NVD-003.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-0032021-03-04T07:00:00Z<![CDATA[Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003]]>https://www.globenewswire.com/news-release/2020/12/23/2149882/0/en/Novadip-Biosciences-Receives-Rare-Paediatric-Disease-Priority-Review-and-Orphan-Disease-Designation.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation2020-12-23T11:00:00Z<![CDATA[Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation]]>https://www.globenewswire.com/news-release/2020/07/29/2069291/0/en/Novadip-Biosciences-to-Present-at-the-LifeSci-Partners-Summer-Symposium.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences to Present at the LifeSci Partners Summer Symposium2020-07-29T11:00:00Z<![CDATA[Novadip Biosciences to Present at the LifeSci Partners Summer Symposium]]>https://www.globenewswire.com/news-release/2020/07/29/2069170/0/en/Novadip-Biosciences-to-Present-at-the-LifeSci-Partners-Summer-Symposium.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences to Present at the LifeSci Partners Summer Symposium2020-07-29T06:28:09Z<![CDATA[Novadip Biosciences to Present at the LifeSci Partners Summer Symposium]]>https://www.globenewswire.com/news-release/2020/06/04/2043573/0/en/Novadip-Biosciences-to-unveil-its-3M3-Platform-at-BIO-Digital-2020.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 20202020-06-04T11:00:00Z<![CDATA[Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020]]>https://www.globenewswire.com/news-release/2020/06/04/2043422/0/en/Novadip-Biosciences-to-unveil-its-3M3-Platform-at-BIO-Digital-2020.html?f=22&fvtc=4&fvtv=54868Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 20202020-06-04T06:00:00Z<![CDATA[Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020]]>